Parnax Lab Limited

BSE:506128 Stok Raporu

Piyasa değeri: ₹1.7b

Parnax Lab Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Parnax Lab has been growing earnings at an average annual rate of 55%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 17.8% per year. Parnax Lab's return on equity is 14.3%, and it has net margins of 5.4%.

Anahtar bilgiler

55.0%

Kazanç büyüme oranı

51.0%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi17.5%
Gelir büyüme oranı17.8%
Özkaynak getirisi14.3%
Net Marj5.4%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Parnax Lab nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

BSE:506128 Gelir, gider ve kazançlar (INR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 241,9011032450
31 Mar 241,888962450
31 Dec 231,832882350
30 Sep 231,791982290
30 Jun 231,7961002110
31 Mar 231,676862110
31 Dec 221,746702030
30 Sep 221,785842010
30 Jun 221,711921830
31 Mar 221,630821860
31 Dec 211,362531790
30 Sep 211,10491670
30 Jun 211,00841480
31 Mar 21901-41470
31 Dec 2092821470
30 Sep 20934-81470
30 Jun 20923-281470
31 Mar 20955-291560
31 Dec 19920-231430
30 Sep 19903-111380
30 Jun 191,085271370
31 Mar 191,100331460
31 Dec 181,122261360
30 Sep 181,140291330
30 Jun 181,00221220
31 Mar 181,064111190
31 Dec 171,055311110
30 Sep 171,066411060
30 Jun 171,024361020
31 Mar 1794837960
31 Dec 1692437960
30 Sep 1683129900
30 Jun 1676733840
31 Mar 1671225800
31 Dec 15784301140
30 Sep 15896381150
30 Jun 1597842760
31 Mar 151,03043850
31 Dec 14984341170
30 Sep 14881241150
30 Jun 1477821720
31 Mar 14686251080
31 Dec 1361931630

Kaliteli Kazançlar: 506128 has high quality earnings.

Büyüyen Kar Marjı: 506128's current net profit margins (5.4%) are lower than last year (5.6%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 506128's earnings have grown significantly by 55% per year over the past 5 years.

Büyüme Hızlandırma: 506128's earnings growth over the past year (2.6%) is below its 5-year average (55% per year).

Kazançlar vs. Sektör: 506128 earnings growth over the past year (2.6%) did not outperform the Pharmaceuticals industry 19.1%.

Özkaynak Getirisi

Yüksek ROE: 506128's Return on Equity (14.3%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y